We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£520.00
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States
Price data last checked 79 day(s) ago - refreshing...
Price History & Forecast
Last 12 days • 12 data points (No recent data available)
Price Distribution
Price distribution over 12 days • 1 price levels
Price Analysis
Most common price: £520 (12 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 12 days
Product Specifications
- Format
- paperback
- ASIN
- B0BLQRB2KX
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 10 November 2022
Similar Products You Might Like
98% match
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India
£515.00
31 Jan 2026
98% match
The 2023-2028 Outlook for Erythropoietin Drugs in the United States
£520.00
06 Feb 2026
97% match
The 2023-2028 Outlook for Iron Deficiency Anemia Drugs in the United States
£520.00
31 Jan 2026
97% match
The 2023-2028 Outlook for Anti-Malarial Drugs in the United States
£520.00
25 Jan 2026
97% match
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States
£520.00
29 Jan 2026
97% match
The 2023-2028 Outlook for Over the Counter Drugs in the United States
£520.00
10 Dec 2025
97% match
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States
£520.00
28 Jan 2026
97% match
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
£520.00
14 Jan 2026
97% match
The 2023-2028 Outlook for OTC Drugs in the United States
£520.00
24 Jan 2026
97% match
The 2023-2028 Outlook for Therapeutic Drug Monitoring in the United States
£520.00
22 Jan 2026
97% match
The 2023-2028 Outlook for Diabetes Drugs in the United States
£520.00
10 Dec 2025
97% match
The 2023-2028 Outlook for Anticoagulant Drugs in the United States
£520.00
01 Feb 2026
97% match
The 2023-2028 Outlook for Insomnia Drugs in the United States
£520.00
25 Jan 2026
97% match
The 2023-2028 Outlook for Nocturia Drugs in the United States
£520.00
25 Jan 2026
97% match
The 2023-2028 Outlook for Antiviral Drugs in the United States
£520.00
30 Jan 2026
97% match
The 2023-2028 Outlook for Antifungal Drugs in the United States
£520.00
10 Dec 2025
97% match
The 2023-2028 Outlook for Narcolepsy Drugs in the United States
£520.00
13 Jan 2026
97% match
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in the United States
£520.00
06 Feb 2026
97% match
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States
£520.00
06 Feb 2026
97% match
The 2023-2028 Outlook for Lipopeptide MRSA Drugs in the United States
£520.00
13 Feb 2026
97% match
The 2023-2028 Outlook for Motion Sickness Medications in the United States
£520.00
06 Feb 2026
97% match
The 2023-2028 Outlook for Atopic Dermatitis Drugs in the United States
£520.00
26 Jan 2026
97% match
The 2023-2028 Outlook for Anticoagulant Reversal Drugs in the United States
£520.00
01 Feb 2026
97% match
The 2023-2028 Outlook for Infertility Drugs in the United States
£520.00
21 Jan 2026